Pentixapharm Holding AG Shareholders’ Equity Growth & History (PTP)
Pentixapharm Holding AG's shareholders’ equity was €35.1M for fiscal 2025.
View full Pentixapharm Holding AG company overviewPentixapharm Holding AG annual shareholders’ equity history
| Fiscal year | Period ended | Shareholders’ equity | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | €35.1M | −€14.3M | −29.04% |
| 2024 | 2024-12-31 | €49.4M | €940,000 | +1.94% |
| 2023 | 2023-12-31 | €48.5M | €10.0M | +26.02% |
| 2022 | 2022-12-31 | €38.5M | €10.6M | +37.98% |
| 2021 | 2021-12-31 | €27.9M | — | — |
Pentixapharm Holding AG quarterly shareholders’ equity
| Fiscal quarter | Period ended | Shareholders’ equity | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | €28.5M | −€12.5M | −30.58% |
| Q1 2026 | 2026-03-31 | €32.2M | −€13.3M | −29.18% |
| Q4 2025 | 2025-12-31 | €35.1M | — | — |
| Q3 2025 | 2025-09-30 | €36.7M | — | — |
| Q2 2025 | 2025-06-30 | €41.0M | — | — |
| Q1 2025 | 2025-03-31 | €45.4M | — | — |
Pentixapharm Holding AG shareholders’ equity trends
Between the periods ended 2021-12-31 and 2025-12-31, Pentixapharm Holding AG's shareholders’ equity increased from €27.9M to €35.1M, a change of €7.2M. The latest reported quarter, Q2 2026, shows €28.5M.
What shareholders’ equity means
Shareholders’ equity is the residual accounting value attributable to shareholders after liabilities are subtracted from assets. It can change through earnings, losses, dividends, share issuance, repurchases, and other comprehensive income.
reported shareholders’ equity
TickerStat standardizes stockholders’ or shareholders’ equity reported in company official filings at each balance-sheet date. Negative equity is retained because it can be economically meaningful. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Pentixapharm Holding AG source filings ↗